Aveo shares drop with uncertainty of NDA submission for Fotivda

Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) lost $1.07 (60%) to $0.70 Thursday after the company said it will not submit an NDA to FDA

Read the full 224 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE